Report cover image

Global Benign Prostatic Hyperplasia (BPH) Drugs Competitive Landscape Professional Research Report 2025

Publisher DIResearch
Published Jan 23, 2025
Length 170 Pages
SKU # DIR19532221

Description

Global Benign Prostatic Hyperplasia (BPH) Drugs Competitive Landscape Professional Research Report 2025



Research Summary

Benign Prostatic Hyperplasia (BPH) drugs are medications used in the treatment of an enlarged prostate gland, a condition known as benign prostatic hyperplasia. BPH is a common condition in older men that can cause bothersome urinary symptoms such as frequent urination, weak urine flow, and the need to urinate during the night. BPH drugs work by targeting the underlying mechanisms that contribute to prostate enlargement, such as reducing the production or blocking the action of hormones that promote prostate growth. Common classes of BPH drugs include alpha-blockers, which relax the muscles in the prostate and bladder neck to improve urine flow, and 5-alpha-reductase inhibitors, which inhibit the conversion of testosterone to dihydrotestosterone, a hormone that promotes prostate growth. These medications can help alleviate urinary symptoms, improve urinary flow, and reduce the risk of complications associated with BPH. The choice of BPH drug depends on factors such as the severity of symptoms, prostate size, patient preferences, and overall health. It is important to consult with a healthcare professional for proper evaluation, diagnosis, and determination of the most appropriate BPH treatment approach.

According to DIResearch's in-depth investigation and research, the global Benign Prostatic Hyperplasia (BPH) Drugs market size was valued at XX Million USD in 2024 and is projected to reach XX Million USD by 2032, with a CAGR of XX% (2025-2032). Notably, the China market has changed rapidly in the past few years. By 2024, China's market size is expected to be XX Million USD, representing approximately XX% of the global market share. By 2032, it is anticipated to grow further to XX Million USD, contributing XX% to the worldwide market share.

The major global  manufacturers of Benign Prostatic Hyperplasia (BPH) Drugs include Eli Lilly, GlaxoSmithKline, Astellas Pharma, Sanofi, Abbott, Pfizer, TEVA, Allergan, Mylan, Novartis, Merck etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.

This report studies the market size, price trends and future development prospects of Benign Prostatic Hyperplasia (BPH) Drugs. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Benign Prostatic Hyperplasia (BPH) Drugs market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Benign Prostatic Hyperplasia (BPH) Drugs market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Benign Prostatic Hyperplasia (BPH) Drugs industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.  

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of Benign Prostatic Hyperplasia (BPH) Drugs Include:

Eli Lilly

GlaxoSmithKline

Astellas Pharma

Sanofi

Abbott

Pfizer

TEVA

Allergan

Mylan

Novartis

Merck

Benign Prostatic Hyperplasia (BPH) Drugs Product Segment Include:

Alpha-Blocker

Phosphodiesterase Type-5 Inhibitors

Others

Benign Prostatic Hyperplasia (BPH) Drugs Product Application Include:

Hospitals

Drugstores

Others

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global Benign Prostatic Hyperplasia (BPH) Drugs Industry PESTEL Analysis

Chapter 3: Global Benign Prostatic Hyperplasia (BPH) Drugs Industry Porter’s Five Forces Analysis

Chapter 4: Global Benign Prostatic Hyperplasia (BPH) Drugs Major Regional Market Size and Forecast Analysis

Chapter 5: Global Benign Prostatic Hyperplasia (BPH) Drugs Market Size and Forecast by Type and Application Analysis

Chapter 6: North America Passenger Benign Prostatic Hyperplasia (BPH) Drugs Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 7: Europe Benign Prostatic Hyperplasia (BPH) Drugs Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: China Benign Prostatic Hyperplasia (BPH) Drugs Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: APAC (Excl. China) Benign Prostatic Hyperplasia (BPH) Drugs Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: Latin America Benign Prostatic Hyperplasia (BPH) Drugs Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Middle East and Africa Benign Prostatic Hyperplasia (BPH) Drugs Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Global Benign Prostatic Hyperplasia (BPH) Drugs Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)

Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)

Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 15: Research Findings and Conclusion

Chapter 16: Methodology and Data Sources

Table of Contents

170 Pages
1 Benign Prostatic Hyperplasia (BPH) Drugs Market Overview
1.1 Product Definition and Statistical Scope
1.2 Benign Prostatic Hyperplasia (BPH) Drugs Product by Type
1.2.1 Alpha-Blocker
1.2.2 Phosphodiesterase Type-5 Inhibitors
1.2.3 Others
1.3 Benign Prostatic Hyperplasia (BPH) Drugs Product by Application
1.3.1 Hospitals
1.3.2 Drugstores
1.3.3 Others
1.4 Global Benign Prostatic Hyperplasia (BPH) Drugs Market Size Analysis (2020-2032)
1.5 Benign Prostatic Hyperplasia (BPH) Drugs Market Development Status and Trends
1.5.1 Benign Prostatic Hyperplasia (BPH) Drugs Industry Development Status Analysis
1.5.2 Benign Prostatic Hyperplasia (BPH) Drugs Industry Development Trends Analysis
2 Benign Prostatic Hyperplasia (BPH) Drugs Market PESTEL Analysis
2.1 Political Factors Analysis
2.2 Economic Factors Analysis
2.3 Social Factors Analysis
2.4 Technological Factors Analysis
2.5 Environmental Factors Analysis
2.6 Legal Factors Analysis
3 Benign Prostatic Hyperplasia (BPH) Drugs Market Porter's Five Forces Analysis
3.1 Competitive Rivalry
3.2 Threat of New Entrants
3.3 Bargaining Power of Suppliers
3.4 Bargaining Power of Buyers
3.5 Threat of Substitutes
4 Global Benign Prostatic Hyperplasia (BPH) Drugs Market Analysis by Regions
4.1 Benign Prostatic Hyperplasia (BPH) Drugs Overall Market: 2024 VS 2025 VS 2032
4.2 Global Benign Prostatic Hyperplasia (BPH) Drugs Revenue and Forecast Analysis (2020-2032)
4.2.1 Global Benign Prostatic Hyperplasia (BPH) Drugs Revenue and Market Share by Region (2020-2025)
4.2.2 Global Benign Prostatic Hyperplasia (BPH) Drugs Revenue Forecast by Region (2026-2032)
5 Global Benign Prostatic Hyperplasia (BPH) Drugs Market Size by Type and Application
5.1 Global Benign Prostatic Hyperplasia (BPH) Drugs Market Size by Type (2020-2032)
5.2 Global Benign Prostatic Hyperplasia (BPH) Drugs Market Size by Application (2020-2032)
6 North America
6.1 North America Benign Prostatic Hyperplasia (BPH) Drugs Market Size and Growth Rate Analysis (2020-2032)
6.2 North America Key Manufacturers Analysis
6.3 North America Benign Prostatic Hyperplasia (BPH) Drugs Market Size by Type
6.4 North America Benign Prostatic Hyperplasia (BPH) Drugs Market Size by Application
6.5 North America Benign Prostatic Hyperplasia (BPH) Drugs Market Size by Country
6.5.1 US
6.5.2 Canada
7 Europe
7.1 Europe Benign Prostatic Hyperplasia (BPH) Drugs Market Size and Growth Rate Analysis (2020-2032)
7.2 Europe Key Manufacturers Analysis
7.3 Europe Benign Prostatic Hyperplasia (BPH) Drugs Market Size by Type
7.4 Europe Benign Prostatic Hyperplasia (BPH) Drugs Market Size by Application
7.5 Europe Benign Prostatic Hyperplasia (BPH) Drugs Market Size by Country
7.5.1 Germany
7.5.2 France
7.5.3 United Kingdom
7.5.4 Italy
7.5.5 Spain
7.5.6 Benelux
8 China
8.1 China Benign Prostatic Hyperplasia (BPH) Drugs Market Size and Growth Rate Analysis (2020-2032)
8.2 China Key Manufacturers Analysis
8.3 China Benign Prostatic Hyperplasia (BPH) Drugs Market Size by Type
8.4 China Benign Prostatic Hyperplasia (BPH) Drugs Market Size by Application
9 APAC (excl. China)
9.1 APAC (excl. China) Benign Prostatic Hyperplasia (BPH) Drugs Market Size and Growth Rate Analysis (2020-2032)
9.2 APAC (excl. China) Key Manufacturers Analysis
9.3 APAC (excl. China) Benign Prostatic Hyperplasia (BPH) Drugs Market Size by Type
9.4 APAC (excl. China) Benign Prostatic Hyperplasia (BPH) Drugs Market Size by Application
9.5 APAC (excl. China) Benign Prostatic Hyperplasia (BPH) Drugs Market Size by Country
9.5.1 Japan
9.5.2 South Korea
9.5.3 India
9.5.4 Australia
9.5.5 Southeast Asia
10 Latin America
10.1 Latin America Benign Prostatic Hyperplasia (BPH) Drugs Market Size and Growth Rate Analysis (2020-2032)
10.2 Latin America Key Manufacturers Analysis
10.3 Latin America Benign Prostatic Hyperplasia (BPH) Drugs Market Size by Type
10.4 Latin America Benign Prostatic Hyperplasia (BPH) Drugs Market Size by Application
10.5 Latin America Benign Prostatic Hyperplasia (BPH) Drugs Market Size by Country
10.5.1 Mexico
10.5.2 Brazil
11 Middle East & Africa
11.1 Middle East & Africa Benign Prostatic Hyperplasia (BPH) Drugs Market Size and Growth Rate Analysis (2020-2032)
11.2 Middle East & Africa Key Manufacturers Analysis
11.3 Middle East & Africa Benign Prostatic Hyperplasia (BPH) Drugs Market Size by Type
11.4 Middle East & Africa Benign Prostatic Hyperplasia (BPH) Drugs Market Size by Application
11.5 Middle East & Africa Benign Prostatic Hyperplasia (BPH) Drugs Market Size by Country
11.5.1 Saudi Arabia
11.5.2 South Africa
12 Competition by Manufacturers
12.1 Global Benign Prostatic Hyperplasia (BPH) Drugs Market Revenue by Key Manufacturers (2021-2025)
12.2 Benign Prostatic Hyperplasia (BPH) Drugs Competitive Landscape Analysis and Market Dynamic
12.2.1 Benign Prostatic Hyperplasia (BPH) Drugs Competitive Landscape Analysis
12.2.2 Global Key Manufacturers Headquarter Location and Key Area Sales
12.2.3 Market Dynamic
13 Key Companies Analysis
13.1 Eli Lilly
13.1.1 Eli Lilly Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.1.2 Eli Lilly Benign Prostatic Hyperplasia (BPH) Drugs Product Portfolio
13.1.3 Eli Lilly Benign Prostatic Hyperplasia (BPH) Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.2 GlaxoSmithKline
13.2.1 GlaxoSmithKline Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.2.2 GlaxoSmithKline Benign Prostatic Hyperplasia (BPH) Drugs Product Portfolio
13.2.3 GlaxoSmithKline Benign Prostatic Hyperplasia (BPH) Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.3 Astellas Pharma
13.3.1 Astellas Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.3.2 Astellas Pharma Benign Prostatic Hyperplasia (BPH) Drugs Product Portfolio
13.3.3 Astellas Pharma Benign Prostatic Hyperplasia (BPH) Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.4 Sanofi
13.4.1 Sanofi Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.4.2 Sanofi Benign Prostatic Hyperplasia (BPH) Drugs Product Portfolio
13.4.3 Sanofi Benign Prostatic Hyperplasia (BPH) Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.5 Abbott
13.5.1 Abbott Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.5.2 Abbott Benign Prostatic Hyperplasia (BPH) Drugs Product Portfolio
13.5.3 Abbott Benign Prostatic Hyperplasia (BPH) Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.6 Pfizer
13.6.1 Pfizer Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.6.2 Pfizer Benign Prostatic Hyperplasia (BPH) Drugs Product Portfolio
13.6.3 Pfizer Benign Prostatic Hyperplasia (BPH) Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.7 TEVA
13.7.1 TEVA Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.7.2 TEVA Benign Prostatic Hyperplasia (BPH) Drugs Product Portfolio
13.7.3 TEVA Benign Prostatic Hyperplasia (BPH) Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.8 Allergan
13.8.1 Allergan Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.8.2 Allergan Benign Prostatic Hyperplasia (BPH) Drugs Product Portfolio
13.8.3 Allergan Benign Prostatic Hyperplasia (BPH) Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.9 Mylan
13.9.1 Mylan Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.9.2 Mylan Benign Prostatic Hyperplasia (BPH) Drugs Product Portfolio
13.9.3 Mylan Benign Prostatic Hyperplasia (BPH) Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.10 Novartis
13.10.1 Novartis Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.10.2 Novartis Benign Prostatic Hyperplasia (BPH) Drugs Product Portfolio
13.10.3 Novartis Benign Prostatic Hyperplasia (BPH) Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.11 Merck
13.11.1 Merck Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.11.2 Merck Benign Prostatic Hyperplasia (BPH) Drugs Product Portfolio
13.11.3 Merck Benign Prostatic Hyperplasia (BPH) Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
14 Industry Chain Analysis
14.1 Benign Prostatic Hyperplasia (BPH) Drugs Industry Chain Analysis
14.2 Benign Prostatic Hyperplasia (BPH) Drugs Industry Raw Material and Suppliers Analysis
14.2.1 Benign Prostatic Hyperplasia (BPH) Drugs Key Raw Material Supply Analysis
14.2.2 Raw Material Suppliers and Contact Information
14.3 Benign Prostatic Hyperplasia (BPH) Drugs Typical Downstream Customers
14.4 Benign Prostatic Hyperplasia (BPH) Drugs Sales Channel Analysis
15 Research Findings and Conclusion
16 Methodology and Data Source
16.1 Methodology/Research Approach
16.2 Research Scope
16.3 Benchmarks and Assumptions
16.4 Date Source
16.4.1 Primary Sources
16.4.2 Secondary Sources
16.5 Data Cross Validation
16.6 Disclaimer

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us